# Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

> **NCT04830982** · PHASE1 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Myocardial Stunning

## Interventions

- **DRUG:** IV Diazoxide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04830982
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn in IRB.
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04830982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04830982, "Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04830982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*